Vafseo ® (vadadustat) is a once-daily oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor to treat anemia due ...

Turkish drugmaker Er-Kim has signed a distribution agreement with Germany’s MEDICE Health Family to commercialize Vafseo ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

ISM5411 was well tolerated and demonstrated a favourable pharmokinetic profile in validating gut-restrictive properties.

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

Akebia has since engaged with the FDA on potentially expanding vadadustat treatment to this patient population and has received feedback on a protocol submitted for a Phase 3 cardiovascular outcome ...

Geode Capital Management LLC raised its holdings in shares of FibroGen, Inc. (NASDAQ:FGEN – Free Report) by 3.1% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC ...

Pre-Market: 7:00:00 a.m. EST Loading Chart for AKBA ...

After hours: January 10 at 7:37:55 p.m. EST ...